Eaton Vance Worldwide Health Sciences is an acceptable but not an exceptional source of exposure to its target sector, and all its share classes retain their Morningstar Analyst Ratings of Neutral.
NAV / 1-Day Return
14.72 / 0.20 %
Adj. Expense Ratio
Longest Manager Tenure
Investment StyleLarge Growth
Min. Initial Investment
Morningstar’s Fund Analysis ERHSX
Will ERHSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.